FDA Inspection
BSO LLCBSO LLC – FDA Inspection, Jul 3, 2024
Record Details
This FDA Inspection record concerns BSO LLC, with an inspection on July 3, 2024, covering drugs.
- Company
- BSO LLC
- Inspection Date
- July 3, 2024
- Product Type
- Drugs
View Company Profile
ID · 306d1fb5-fe5e-4659-9bc8-94f020373bf2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1243627
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.25(a)Training , Education , Experience overall
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BSO LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2025 | OAI | Denver District Office | Drug Quality Assurance |
| March 11, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 2, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSO LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.